Department of Pathology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
Division of Pathology, Department of Medicine-DIMED, Pathology Unit, Padova, Italy.
Mod Pathol. 2014 Mar;27(3):472-91. doi: 10.1038/modpathol.2013.80. Epub 2013 Sep 6.
Liver tumors are rare in children, and their diagnoses may be challenging particularly because of the lack of a current consensus classification system. Systematic central histopathological review of these tumors performed as part of the pediatric collaborative therapeutic protocols has allowed the identification of histologic subtypes with distinct clinical associations. As a result, histopathology has been incorporated within the Children's Oncology Group (COG) protocols, and only in the United States, as a risk-stratification parameter and for patient management. Therefore, the COG Liver Tumor Committee sponsored an International Pathology Symposium in March 2011 to discuss the histopathology and classification of pediatric liver tumors, and hepatoblastoma in particular, and work towards an International Pediatric Liver Tumors Consensus Classification that would be required for international collaborative projects. Twenty-two pathologists and experts in pediatric liver tumors, including those serving as central reviewers for the COG, European Société Internationale d'Oncologie Pédiatrique, Gesellschaft für Pädiatrische Onkologie und Hämatologie, and Japanese Study Group for Pediatric Liver Tumors protocols, as well as pediatric oncologists and surgeons specialized in this field, reviewed more than 50 pediatric liver tumor cases and discussed classic and newly reported entities, as well as criteria for their classification. This symposium represented the first collaborative step to develop a classification that may lead to a common treatment-stratification system incorporating tumor histopathology. A standardized, clinically meaningful classification will also be necessary to allow the integration of new biological parameters and to move towards clinical algorithms based on patient characteristics and tumor genetics, which should improve future patient management and outcome.
肝脏肿瘤在儿童中较为罕见,其诊断可能颇具挑战性,特别是因为目前缺乏共识性的分类系统。这些肿瘤的系统中心组织病理学审查是儿科协作治疗方案的一部分,有助于识别具有不同临床关联的组织学亚型。因此,组织病理学已被纳入儿童肿瘤协作组(COG)方案,仅在美国,它被用作风险分层参数和患者管理的依据。因此,COG 肝脏肿瘤委员会于 2011 年 3 月举办了一次国际病理学研讨会,讨论小儿肝脏肿瘤,特别是肝母细胞瘤的组织病理学和分类问题,并致力于制定国际小儿肝脏肿瘤共识分类,这是开展国际合作项目的必要条件。22 名病理学家和小儿肝脏肿瘤专家参加了此次研讨会,包括担任 COG、欧洲小儿肿瘤学会、德国儿科肿瘤与血液学学会、日本小儿肝脏肿瘤研究组方案的中心审查员的专家,以及专门从事该领域的小儿肿瘤学家和外科医生。他们回顾了 50 多例小儿肝脏肿瘤病例,并讨论了经典和新报道的实体瘤,以及它们分类的标准。此次研讨会是制定可能导致纳入肿瘤组织病理学的共同治疗分层系统的首次协作步骤。标准化的、具有临床意义的分类对于纳入新的生物学参数以及根据患者特征和肿瘤遗传学制定临床算法也是必要的,这将有助于改善未来的患者管理和预后。